TRIM14 and neoplasm: Moreover, TRIM14 interacts with GFAT1, a key rate-limiting enzyme in the hexosamine biosynthesis pathway (HBP), and promotes its ubiquitination degradation, thereby inhibiting HBP and playing a tumor-suppressive role [26, 63–66].